Sleep quality in pregnancy. Sleep disorders
Conditions
Interventions
Intervention 1: Intervention group: myoinositol supplementation powder the ino folic commercial name containing 2000 mg of myoinositol and 200 µg of folic acid (manufactured by the company Lo.Li Pharm
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Conscious written consent Pregnant women with singletone pregnancy Age 18 and over Gestational age of 14 weeks Absence of chronic physical diseases such as diabetes, high blood pressure and cardiovascular disease No history of taking prenatal drugs before pregnancy No history of sleep disorders before pregnancy Working women without night shift work Non-smoking and alcohol Lack of history of psychiatric use No history of abortion in previous pregnancies
Exclusion criteria
Exclusion criteria: Severe depression or severe stress Death experience of one of the first-degree relatives during pregnancy Changes in sleep status due to travel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep Quality Score in Pittsburgh Sleep Quality Questionnaire. Timepoint: In the second trimester of pregnancy at weeks 24 to 28 and in the third trimester of pregnancy at weeks 37 to 38 of pregnancy. Method of measurement: Pittsburgh Sleep Quality Index Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Neonatal and pregnancy outcomes. Timepoint: The end of pregnancy for the outcome of pregnancy and infancy Method of measurement. Method of measurement: Questionnaire and complete the checklist using file.;Side effect of drug. Timepoint: In the second trimester of pregnancy (week 24-28) and the third trimester of pregnancy (week 37_38). Method of measurement: Drug side effect checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMolood Aghajani Delavar
Babol University of Medical Sciences
Outcome results
None listed